Hidradenitis SuppurativaSkin
What this study is
This study will create and extend a source of clinical specimens for the future study of inflammatory skin disorders.
Study details
- Sponsor
- Ohio State University
- Conditions
- Hidradenitis Suppurativa
- Enrolling
- 175 people
- Starts
- 2017-04-19
- Est. completion
- 2030-12-31
- Record
- View on ClinicalTrials.gov ↗
Who can join
Sex ALLHealthy volunteers AcceptedYou may qualify if
- Seen by an Ohio State University (OSU) Dermatology provider on the main University Hospital campus, including the James Cancer Hospital, OSU Dermatology East, OSU Dermatology at the Ohio State Eye and Ear Institute, Martha Morehouse Medical Pavilion, and OSU Dermatology at Upper Arlington after the date of approval of this protocol
- Ability to provide informed consent, or parent or legal guardian capable of providing consent for child or mentally handicapped individuals
- Willingness to participate in a research study.
You can't join if
- Inability to provide informed consent
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openOSU Dermatology West
Columbus, Ohio, United States
- Erin Frey · Contact614-366-2025erin.frey@osumc.edu
- Cerah McDaniels-Wilson · ContactCerah.McDanielsWilson@osumc.edu
- Benjamin Kaffenberger, MD · Principal investigator
Recruiting
Study team
Sponsor
Ohio State University
Study ID 2010H0331
Principal investigator
Benjamin Kaffenberger, MD
Dermatologist
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.